November 10, 2014
BIONOR PHARMA is a leading vaccine company searching for breakthrough treatments for HIV and other lethal viruses [ www.bionorpharma.com ].
September 23, 2014
VAC-3S vaccine, a novel approach to the therapeutic management of HIV Infection. Overview of phase I and phase II clinical vaccine development programs. R Ho Tsong Fang, O Launay, C Katlama, J Crouzet, B Autran, V Vieillard, P Debré, S Gharakhanian 2014.09 VAC-3S J Vaccines Vaccin 2014.55
April 6, 2014
The talk titled “New Initiatives in Academic Commercialization” highlights the University of Pennsylvania – UPenn – UPStart Program and the collaboration with NovoBioPharma a firm co-founded by Shahin Gharakhanian MD Consulting LLC. This is a new collaboration set up to provide innovative business and science solutions for academia-based early...
December 2, 2013
FINAL_InnaVirVax_VAC3S_WorldAIDS DayDec2013
October 15, 2013
2013 AIDS Vaccine Poster P1357
September 12, 2013
NBP UPStart PR 09.04.2013
June 12, 2013
NOVOBIOPHARMA Launch 61013
June 3, 2013
Organized at the Pasteur Institute, Paris, France 21-23 May 2013. 2013 VAC3S Poster no 145 Institut Pasteur Paris May
May 12, 2013
“Precision Medicine / Personalized Medicine & HIV Infection: Concepts and Applications ?” Paris: 25 April 2013 [www.anrs.fr]
March 17, 2013
Shahin Gharakhanian statement in the latest Press Release from InnaVirVax issued during the Conference on Retroviruses, 3-6 March 2013, Atlanta GA, USA. Reference: Katlama Ch, Launay O, Ho Tsong Fang R, Bodilis H, Calin R, Autran B, Gharakhanian S, Vieillard V, J Crouzet J, Debré P. A randomized, placebo-controlled, double-blind, phase I/IIa...